Philips Digital & Computational Pathology. Credit: Koninklijke Philips N.V.

Health technology major Royal Philips has introduced an updated version of its TissueMark computational pathology solution software at Euskalduna Conference Centre in Bilbao, Spain.

The new TissueMark version leverages artificial intelligence (AI) to support region of interest detection for molecular testing as well as assists research labs in enhancing the accuracy of tumour estimation.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

It will also offer tumour sufficiency guidance for lung histology, lung cytology, colon and breast tissue samples along with whole slide images (WSI) of adenocarcinoma prostate tissue as well as high-grade serous carcinoma ovarian tissue.

“The new TissueMark version leverages artificial intelligence to support region of interest detection for molecular testing as well as assists research labs in enhancing the accuracy of tumour estimation.”

Philips digital and computational pathology general manager Marlon Thompson said: “Using a microscope for tumour estimation is subjective and leads to high variability amongst pathologists.

“By digitising the tissue slide and analysing the image with robust computational software and intelligent algorithms, we can better support pathologists’ workflows and help labs enhance quality and reliability while reducing costs by limiting the number of molecular tests performed with insufficient tumour content.”

In addition, the company aims to support pathologists’ workflows by digitising the tissue slide and uses computational software and intelligent algorithms to analyse the image.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

This will assist labs to improve quality and reliability as well as reduce costs by limiting the number of molecular tests performed with insufficient tumour content.

Earlier this year, the technology company unveiled its AI platform for healthcare.